WHO’s director of antimicrobial resistance, Dr Yvan Hutin, says science needs to catch up with drug-resistant bacteria.

In a bid to combat the rising threat of antibacterial resistance, researchers from the Research Center for Biomass and Bioproducts, National Research and Innovation Agency (BRIN), have delved into the ...

​As per WHO data, AMR is an urgent global public health threat, killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019.

A team of nanochemists at Soochow University, in China, working with a colleague from Columbia University, in the U.S., has developed an inhalable antibacterial therapy carried by nanoparticles for ...

The global preclinical antibacterial pipeline refers to innovative antibacterial candidate drugs that are under development with the aim of effectively eliminating newly emerged and pre-existing ...

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

Antimicrobial nanoparticles are materials with exceptional antimicrobial properties, capable of controlling bacterial, viral, and fungal infections. Thanks to their unique physicochemical attributes, ...

Please provide your email address to receive an email when new articles are posted on . The number of antibacterial agents in clinical and preclinical development decreased from 97 to 90. Of these, 40 ...

Long overlooked as a benign resident of the oral microbiome, Fusobacterium nucleatum has been increasingly linked to cancer progression, metastasis, and chemotherapeutic resistance. Now, researchers ...